Advisory Board, in partnership with Medtronic, recently held a webinar to discuss lessons learned from Covid-19 on a global scale and strategies to respond to future surges. If you missed the live session, here are three takeaways to help prepare for Covid-19’s “second wave”:
The virus path will look different in terms of patient makeup, geographic hot spots, and shortages. For instance, the first wave of Covid-19 largely affected middle-aged and older adults, whereas the “second wave” is mainly affecting younger adults. Additionally, we initially worried about urban bed capacity and PPE. Now, the main concern is rural bed capacity and staffing shortages. Health systems will need to shift their attention and resources to support these new focus areas.
Public health officials have expressed concern about the flu season’s impact on existing Covid-19 challenges. However, countries in the Southern Hemisphere have shown record low rates of influenza toward the end of their season likely due to high vaccination rates and widespread public health measures. Northern Hemisphere countries can similarly increase vaccination rates by shifting vaccination efforts to churches or pharmacies or even incentivizing the public through reduced costs.
Covid-19 has forced health systems to coordinate more effectively across their care sites and find innovative ways to treat Covid-19 patients and handle surges. Below are three examples of organizations who function as coordinated systems:
While the finish line is still a vaccine, it will take a global approach to eradicate Covid-19. Advisory Board and Medtronic have partnered to deliver a series of webinars for hospital administrators specific to Covid-19 that you can access here. View the July and October webinars on-demand and register for the December 2, 2020, and January 13, 2021, scheduled webinars.
At Medtronic, we believe in the power of medical technology to improve lives. Seven decades ago, our co-founder invented the battery-powered pacemaker. Today, we are among the largest medical device companies in the world. With operations in 150 countries, our products treat 70 health conditions and include cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Our therapies help 72 million people a year and support our Mission to alleviate pain, restore health, and extend life.
This blog post is sponsored by Medtronic, an Advisory Board member organization. Representatives of Medtronic helped select the topics and issues addressed. Advisory Board experts wrote the post, maintained final editorial approval, and conducted the underlying research independently and objectively. Advisory Board does not endorse any company, organization, product or brand mentioned herein.
Create your free account to access 2 resources each month, including the latest research and webinars.
You have 2 free members-only resources remaining this month remaining this month.
Never miss out on the latest innovative health care content tailored to you.